{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:24:04Z","timestamp":1793852644111,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hunan Provincial Natural Science Youth Fund","award":["2021JJ4002"],"award-info":[{"award-number":["2021JJ4002"]}]},{"name":"Hunan Provincial Natural Science Youth Fund","award":["2021JJ4002"],"award-info":[{"award-number":["2021JJ4002"]}]},{"name":"Hunan Provincial Key Fields Research and Development Plan","award":["2020SKC2007"],"award-info":[{"award-number":["2020SKC2007"]}]},{"name":"Hunan Provincial Key Fields Research and Development Plan","award":["2020SKC2007"],"award-info":[{"award-number":["2020SKC2007"]}]},{"name":"Hunan Provincial Key Fields Research and Development Plan","award":["2020SKC2007"],"award-info":[{"award-number":["2020SKC2007"]}]},{"name":"Hunan Provincial Key Fields Research and Development Plan","award":["2020SKC2007"],"award-info":[{"award-number":["2020SKC2007"]}]},{"name":"Hunan Provincial Key Fields Research and Development Plan","award":["2020SKC2007"],"award-info":[{"award-number":["2020SKC2007"]}]},{"name":"Hunan Provincial Key Fields Research and Development Plan","award":["2020SKC2007"],"award-info":[{"award-number":["2020SKC2007"]}]},{"name":"Hunan Provincial Key Fields Research and Development Plan","award":["2020SKC2007"],"award-info":[{"award-number":["2020SKC2007"]}]},{"name":"Hunan Provincial Key Fields Research and Development Plan","award":["2020SKC2007"],"award-info":[{"award-number":["2020SKC2007"]}]},{"name":"Hunan Provincial Natural Science Fund","award":["2021JJ30046"],"award-info":[{"award-number":["2021JJ30046"]}]},{"name":"Hunan Provincial Natural Science Fund","award":["2023JJ70047"],"award-info":[{"award-number":["2023JJ70047"]}]},{"name":"Hunan Provincial Natural Science Fund","award":["2021JJ30046"],"award-info":[{"award-number":["2021JJ30046"]}]},{"name":"Hunan Provincial Innovation Platform and Specialist Program of Foreign Experts Fund","award":["2022WZ1023"],"award-info":[{"award-number":["2022WZ1023"]}]},{"name":"Hunan Provincial Innovation Platform and Specialist Program of Foreign Experts Fund","award":["2022WZ1023"],"award-info":[{"award-number":["2022WZ1023"]}]},{"name":"Hunan Provincial Innovation Platform and Specialist Program of Foreign Experts Fund","award":["2022WZ1023"],"award-info":[{"award-number":["2022WZ1023"]}]},{"name":"Medical Research Council","award":["MR\/W004682\/1"],"award-info":[{"award-number":["MR\/W004682\/1"]}]},{"name":"Science Research Foundation of Aier Eye Hospital Group","award":["AM2201D02"],"award-info":[{"award-number":["AM2201D02"]}],"id":[{"id":"https:\/\/ror.org\/02fz07e24","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neovascular age-related macular degeneration (nAMD) is a major cause of blindness in the elderly. The disease is due to the growth of abnormal blood vessels into the macula, leading to the loss of central vision. Intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors (e.g., anti-VEGF) is the standard of care for nAMD. However, nearly 50% of patients do not respond or respond poorly to the therapy. More importantly, up to 70% of nAMD patients develop macular fibrosis after 10\u00a0years of anti-VEGF therapy. The underlying mechanism of nAMD-mediated macular fibrosis is unknown although inflammation is known to play an important role in the development of abnormal macular blood vessels and its progression to fibro-vascular membrane. In this study, we measured the intraocular levels of adhesion molecule VCAM-1, ICAM-1, CD44, CD62L, and CD62P in nAMD patients with and without macular fibrosis and investigated the link between the levels of adhesion molecule and clinical features (e.g., visual improvement, retinal thickness, etc.). We further investigated the effect of VCAM-1 in macrophage function in vitro and the development of subretinal fibrosis in vivo using a two-stage laser-induced protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The aqueous levels of ICAM-1, VCAM-1, CD44, and CD62L were significantly higher in nAMD patients compared to cataract controls. The aqueous level of VCAM-1 (but not other adhesion molecules) was significantly higher in patients with macular fibrosis than those without and the level correlated positively with the retinal thickness. VCAM-1 was highly expressed at the lesion site in the mouse model of subretinal fibrosis. Blocking VCAM-1 or its receptor VLA-4 significantly\u00a0prevented macrophage infiltration and reduced subretinal fibrosis in vivo. VCAM-1 induced macrophage migration and upregulated the expression of\n                      <jats:italic>Arg-1, Mmp12<\/jats:italic>\n                      and\n                      <jats:italic>Il6<\/jats:italic>\n                      but down-regulated the expression of\n                      <jats:italic>iNOS<\/jats:italic>\n                      and\n                      <jats:italic>Il1b<\/jats:italic>\n                      in macrophages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>VCAM-1 may contribute to the development of macular fibrosis in nAMD patients by modulating macrophage functions, including migration and profibrotic polarization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12979-023-00389-x","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:02:29Z","timestamp":1700460149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Vascular Cell Adhesion Molecule-1 (VCAM-1) contributes to\u00a0macular fibrosis in neovascular age-related macular degeneration through modulating macrophage functions"],"prefix":"10.1186","volume":"20","author":[{"given":"Wen","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijiao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengchao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"issue":"10153","key":"389_CR1","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/s0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147\u201359. https:\/\/doi.org\/10.1016\/s0140-6736(18)31550-2.","journal-title":"Lancet"},{"key":"389_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, Cheung CMG. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res. 2016;53:107\u201339. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.04.002.","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"389_CR3","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1136\/bjophthalmol-2018-312944","volume":"103","author":"A Invernizzi","year":"2019","unstructured":"Invernizzi A, Teo K, Nguyen V, Daniell M, Squirrell D, Barthelmes D, Gillies MC. Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months. Br J Ophthalmol. 2019;103(9):1337\u201341. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312944.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"389_CR4","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1038\/s41433-022-02153-9","volume":"36","author":"U Chakravarthy","year":"2022","unstructured":"Chakravarthy U, Armendariz BG, Fauser S. 15 years of anti-VEGF treatment for nAMD: success or failure or something in between? Eye (Lond). 2022;36(12):2232\u20133. https:\/\/doi.org\/10.1038\/s41433-022-02153-9.","journal-title":"Eye (Lond)"},{"issue":"11","key":"389_CR5","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1136\/bjophthalmol-2013-303513","volume":"97","author":"I Krebs","year":"2013","unstructured":"Krebs I, Glittenberg C, Ansari-Shahrezaei S, Hagen S, Steiner I, Binder S. Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration. Br J Ophthalmol. 2013;97(11):1443\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-303513.","journal-title":"Br J Ophthalmol"},{"key":"389_CR6","doi-asserted-by":"publisher","first-page":"16754","DOI":"10.1038\/srep16754","volume":"5","author":"J Lechner","year":"2015","unstructured":"Lechner J, Chen M, Hogg RE, Toth L, Silvestri G, Chakravarthy U, Xu H. Alterations in circulating immune cells in neovascular age-related macular degeneration. Sci Rep. 2015;5:16754. https:\/\/doi.org\/10.1038\/srep16754.","journal-title":"Sci Rep"},{"issue":"8","key":"389_CR7","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","volume":"123","author":"MG Maguire","year":"2016","unstructured":"Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, Toth CA, Ferris FL 3rd, Fine SL. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016;123(8):1751\u201361. https:\/\/doi.org\/10.1016\/j.ophtha.2016.03.045.","journal-title":"Ophthalmology"},{"issue":"5","key":"389_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/ceo.13742","volume":"48","author":"B Wolff","year":"2020","unstructured":"Wolff B, Macioce V, Vasseur V, Castelnovo L, Michel G, Nguyen V, Daien V, Mauget-Fa\u00ffsse M, Gillies M. Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: a single-centre French study. Clin Experiment Ophthalmol. 2020;48(5):636\u201343. https:\/\/doi.org\/10.1111\/ceo.13742.","journal-title":"Clin Experiment Ophthalmol"},{"key":"389_CR9","doi-asserted-by":"publisher","unstructured":"Teo KYC, Joe AW, Nguyen V, Invernizzi A, Arnold JJ, Barthelmes D, Gillies M. Prevalence and risk factors for the development of physician-graded subrerinal fibrosis in eyes treated for neovascular age-related macular degeneration. Retina 2020. https:\/\/doi.org\/10.1097\/iae.0000000000002779.","DOI":"10.1097\/iae.0000000000002779"},{"issue":"2","key":"389_CR10","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1111\/aos.14905","volume":"100","author":"S Llorente-Gonz\u00e1lez","year":"2022","unstructured":"Llorente-Gonz\u00e1lez S, Hernandez M, Gonz\u00e1lez-Zamora J, Bilbao-Malav\u00e9 V, Fern\u00e1ndez-Robredo P, Saenz-de-Viteri M, Barrio-Barrio J, Rodr\u00edguez-Cid MJ, Donate J, Ascaso FJ, G\u00f3mez-Ram\u00edrez AM, Araiz J, Armad\u00e1 F, Ruiz-Moreno \u00d3, Recalde S, Garc\u00eda-Layana A. The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world. Acta Ophthalmol. 2022;100(2):e521\u201331. https:\/\/doi.org\/10.1111\/aos.14905.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"389_CR11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1189\/jlb.3RI0615-239R","volume":"98","author":"M Chen","year":"2015","unstructured":"Chen M, Xu H. Parainflammation, chronic inflammation, and age-related macular degeneration. J Leukoc Biol. 2015;98(5):713\u201325. https:\/\/doi.org\/10.1189\/jlb.3RI0615-239R.","journal-title":"J Leukoc Biol"},{"key":"389_CR12","doi-asserted-by":"publisher","unstructured":"Arrigo A, Aragona E, Bandello F. The role of inflammation in age-related macular degeneration: updates and possible therapeutic approaches. Asia Pac J Ophthalmol (Phila). 2022. https:\/\/doi.org\/10.1097\/apo.0000000000000570.","DOI":"10.1097\/apo.0000000000000570."},{"issue":"4","key":"389_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1566524016666160324130031","volume":"16","author":"M Chen","year":"2016","unstructured":"Chen M, Lechner J, Zhao J, Toth L, Hogg R, Silvestri G, Kissenpfennig A, Chakravarthy U, Xu H. STAT3 activation in circulating monocytes contributes to neovascular age-related macular degeneration. Curr Mol Med. 2016;16(4):412\u201323. https:\/\/doi.org\/10.2174\/1566524016666160324130031.","journal-title":"Curr Mol Med"},{"issue":"1","key":"389_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12974-017-0820-y","volume":"14","author":"J Lechner","year":"2017","unstructured":"Lechner J, Chen M, Hogg RE, Toth L, Silvestri G, Chakravarthy U, Xu H. Peripheral blood mononuclear cells from neovascular age-related macular degeneration patients produce higher levels of chemokines CCL2 (MCP-1) and CXCL8 (IL-8). J Neuroinflammation. 2017;14(1):42. https:\/\/doi.org\/10.1186\/s12974-017-0820-y.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"389_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12979-020-00205-w","volume":"17","author":"M Chen","year":"2020","unstructured":"Chen M, Yang N, Lechner J, Toth L, Hogg R, Silvestri G, Chakravarthy U, Xu H. Plasma level of lipocalin 2 is increased in neovascular age-related macular degeneration patients, particularly those with macular fibrosis. Immun Ageing. 2020;17(1):35. https:\/\/doi.org\/10.1186\/s12979-020-00205-w.","journal-title":"Immun Ageing"},{"key":"389_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12979-016-0060-5","volume":"13","author":"J Lechner","year":"2016","unstructured":"Lechner J, Chen M, Hogg RE, Toth L, Silvestri G, Chakravarthy U, Xu H. Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: complement activation in AMD. Immun Ageing. 2016;13:4. https:\/\/doi.org\/10.1186\/s12979-016-0060-5.","journal-title":"Immun Ageing"},{"key":"389_CR17","doi-asserted-by":"publisher","first-page":"916719","DOI":"10.3389\/fncel.2022.916719","volume":"16","author":"M Szczepan","year":"2022","unstructured":"Szczepan M, Llori\u00e1n-Salvador M, Chen M, Xu H. Immune cells in subretinal wound healing and fibrosis. Front Cell Neurosci. 2022;16:916719. https:\/\/doi.org\/10.3389\/fncel.2022.916719.","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"389_CR18","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1167\/iovs.14-16012","volume":"56","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Yoshida S, Nakao S, Yoshimura T, Kobayashi Y, Nakama T, Kubo Y, Miyawaki K, Yamaguchi M, Ishikawa K, Oshima Y, Akashi K, Ishibashi T. M2 Macrophages enhance pathological neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2015;56(8):4767\u201377. https:\/\/doi.org\/10.1167\/iovs.14-16012.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"389_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12974-020-02033-7","volume":"17","author":"K Little","year":"2020","unstructured":"Little K, Llori\u00e1n-Salvador M, Tang M, Du X, Marry S, Chen M, Xu H. Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration. J Neuroinflammation. 2020;17(1):355. https:\/\/doi.org\/10.1186\/s12974-020-02033-7.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"389_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-022-02433-x","volume":"19","author":"C Yi","year":"2022","unstructured":"Yi C, Liu J, Deng W, Luo C, Qi J, Chen M, Xu H. Macrophage elastase (MMP12) critically contributes to the development of subretinal fibrosis. J Neuroinflammation. 2022;19(1):78. https:\/\/doi.org\/10.1186\/s12974-022-02433-x.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"389_CR21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1189\/jlb.72.6.1133","volume":"72","author":"H Xu","year":"2002","unstructured":"Xu H, Manivannan A, Liversidge J, Sharp PF, Forrester JV, Crane IJ. Involvement of CD44 in leukocyte trafficking at the blood-retinal barrier. J Leukoc Biol. 2002;72(6):1133\u201341.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"389_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/immu.200310014","volume":"33","author":"IJ Crane","year":"2003","unstructured":"Crane IJ, Xu H, Manivannan A, McKillop-Smith S, Lamont G, Wallace C, Liversidge J, Sharp PF, Forrester JV. Effect of anti-macrophage inflammatory protein-1alpha on leukocyte trafficking and disease progression in experimental autoimmune uveoretinitis. Eur J Immunol. 2003;33(2):402\u201310. https:\/\/doi.org\/10.1002\/immu.200310014.","journal-title":"Eur J Immunol"},{"issue":"5","key":"389_CR23","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.4049\/jimmunol.172.5.3215","volume":"172","author":"H Xu","year":"2004","unstructured":"Xu H, Manivannan A, Jiang HR, Liversidge J, Sharp PF, Forrester JV, Crane IJ. Recruitment of IFN-gamma-producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P\/E-selectin interactions. J Immunol. 2004;172(5):3215\u201324. https:\/\/doi.org\/10.4049\/jimmunol.172.5.3215.","journal-title":"J Immunol"},{"issue":"5","key":"389_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/glia.22315","volume":"60","author":"M Chen","year":"2012","unstructured":"Chen M, Zhao J, Luo C, Pandi SP, Penalva RG, Fitzgerald DC, Xu H. Para-inflammation-mediated retinal recruitment of bone marrow-derived myeloid cells following whole-body irradiation is CCL2 dependent. Glia. 2012;60(5):833\u201342. https:\/\/doi.org\/10.1002\/glia.22315.","journal-title":"Glia"},{"issue":"10","key":"389_CR25","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.4049\/jimmunol.175.10.6915","volume":"175","author":"H Xu","year":"2005","unstructured":"Xu H, Manivannan A, Dawson R, Crane IJ, Mack M, Sharp P, Liversidge J. Differentiation to the CCR2+ inflammatory phenotype in vivo is a constitutive, time-limited property of blood monocytes and is independent of local inflammatory mediators. J Immunol. 2005;175(10):6915\u201323. https:\/\/doi.org\/10.4049\/jimmunol.175.10.6915.","journal-title":"J Immunol"},{"issue":"4","key":"389_CR26","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1182\/blood-2007-06-098327","volume":"112","author":"H Xu","year":"2008","unstructured":"Xu H, Manivannan A, Crane I, Dawson R, Liversidge J. Critical but divergent roles for CD62L and CD44 in directing blood monocyte trafficking in vivo during inflammation. Blood. 2008;112(4):1166\u201374. https:\/\/doi.org\/10.1182\/blood-2007-06-098327.","journal-title":"Blood"},{"issue":"5","key":"389_CR27","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1111\/j.1755-3768.2012.02414.x","volume":"90","author":"JB Jonas","year":"2012","unstructured":"Jonas JB, Tao Y, Neumaier M, Findeisen P. Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol. 2012;90(5):e381\u20138. https:\/\/doi.org\/10.1111\/j.1755-3768.2012.02414.x.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"389_CR28","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1021\/acs.molpharmaceut.8b00661","volume":"15","author":"MI Uddin","year":"2018","unstructured":"Uddin MI, Kilburn TC, Yang R, McCollum GW, Wright DW, Penn JS. Targeted imaging of VCAM-1 mRNA in a mouse model of laser-induced choroidal neovascularization using antisense hairpin-DNA-functionalized gold-nanoparticles. Mol Pharm. 2018;15(12):5514\u201320. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00661.","journal-title":"Mol Pharm"},{"key":"389_CR29","doi-asserted-by":"publisher","first-page":"594087","DOI":"10.3389\/fphar.2020.594087","volume":"11","author":"I Mantel","year":"2020","unstructured":"Mantel I, Borgo A, Guidotti J, Forestier E, Kirsch O, Derradji Y, Waridel P, Burdet F, Mehl F, Schweizer C, Roduit R. Molecular biomarkers of neovascular age-related macular degeneration with incomplete response to anti-vascular endothelial growth factor treatment. Front Pharmacol. 2020;11:594087. https:\/\/doi.org\/10.3389\/fphar.2020.594087.","journal-title":"Front Pharmacol"},{"issue":"10","key":"389_CR30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/archophthalmol.2010.227","volume":"128","author":"JB Jonas","year":"2010","unstructured":"Jonas JB, Tao Y, Neumaier M, Findeisen P. Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol. 2010;128(10):1281\u20136. https:\/\/doi.org\/10.1001\/archophthalmol.2010.227.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"389_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.9.4.3","volume":"9","author":"K Little","year":"2020","unstructured":"Little K, Llorian-Salvador M, Tang M, Du X, O\u2019Shaughnessy O, McIlwaine G, Chen M, Xu H. A two-stage laser-induced mouse model of subretinal fibrosis secondary to choroidal neovascularization. Transl Vis Sci Technol. 2020;9(4):3. https:\/\/doi.org\/10.1167\/tvst.9.4.3.","journal-title":"Transl Vis Sci Technol"},{"key":"389_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-0716-2128-8_8","volume":"2455","author":"R Mendoza","year":"2022","unstructured":"Mendoza R, Banerjee I, Manna D, Reghupaty SC, Yetirajam R, Sarkar D. Mouse bone marrow cell isolation and macrophage differentiation. Methods Mol Biol. 2022;2455:85\u201391. https:\/\/doi.org\/10.1007\/978-1-0716-2128-8_8.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"389_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12974-023-02731-y","volume":"20","author":"C Yi","year":"2023","unstructured":"Yi C, Liu J, Deng W, Luo C, Qi J, Chen M, Xu H. Old age promotes retinal fibrosis in choroidal neovascularization through circulating fibrocytes and profibrotic macrophages. J Neuroinflammation. 2023;20(1):45. https:\/\/doi.org\/10.1186\/s12974-023-02731-y.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"389_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/med.10001","volume":"22","author":"H Yusuf-Makagiansar","year":"2002","unstructured":"Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ. Inhibition of LFA-1\/ICAM-1 and VLA-4\/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev. 2002;22(2):146\u201367. https:\/\/doi.org\/10.1002\/med.10001.","journal-title":"Med Res Rev"},{"issue":"3","key":"389_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/jlb.2mr0220-549r","volume":"108","author":"TM Bui","year":"2020","unstructured":"Bui TM, Wiesolek HL, Sumagin R. ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol. 2020;108(3):787\u201399. https:\/\/doi.org\/10.1002\/jlb.2mr0220-549r.","journal-title":"J Leukoc Biol"},{"issue":"4","key":"389_CR36","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/ijms19041057","volume":"19","author":"DH Kong","year":"2018","unstructured":"Kong DH, Kim YK, Kim MR, Jang JH, Lee S. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int J Mol Sci. 2018;19(4):1057. https:\/\/doi.org\/10.3390\/ijms19041057.","journal-title":"Int J Mol Sci."},{"issue":"4","key":"389_CR37","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1161\/01.cir.93.4.672","volume":"93","author":"KD O'Brien","year":"1996","unstructured":"O\u2019Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation. 1996;93(4):672\u201382. https:\/\/doi.org\/10.1161\/01.cir.93.4.672.","journal-title":"Circulation"},{"issue":"6\u20137","key":"389_CR38","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ejcb.2011.09.003","volume":"91","author":"D Dreymueller","year":"2012","unstructured":"Dreymueller D, Pruessmeyer J, Groth E, Ludwig A. The role of ADAM-mediated shedding in vascular biology. Eur J Cell Biol. 2012;91(6\u20137):472\u201385. https:\/\/doi.org\/10.1016\/j.ejcb.2011.09.003.","journal-title":"Eur J Cell Biol"},{"issue":"46","key":"389_CR39","doi-asserted-by":"publisher","first-page":"38957","DOI":"10.1074\/jbc.M112.357863","volume":"287","author":"YH Kim","year":"2012","unstructured":"Kim YH, Kwon HJ, Kim DS. Matrix metalloproteinase 9 (MMP-9)-dependent processing of \u03b2ig-h3 protein regulates cell migration, invasion, and adhesion. J Biol Chem. 2012;287(46):38957\u201369. https:\/\/doi.org\/10.1074\/jbc.M112.357863.","journal-title":"J Biol Chem"},{"key":"389_CR40","first-page":"142","volume":"27","author":"S Lauwen","year":"2021","unstructured":"Lauwen S, Lefeber DJ, Fauser S, Hoyng CB, den Hollander AI. Increased pro-MMP9 plasma levels are associated with neovascular age-related macular degeneration and with the risk allele of rs142450006 near MMP9. Mol Vis. 2021;27:142\u201350.","journal-title":"Mol Vis"},{"issue":"6","key":"389_CR41","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/sj.eye.6702722x","volume":"22","author":"KY Chau","year":"2008","unstructured":"Chau KY, Sivaprasad S, Patel N, Donaldson TA, Luthert PJ, Chong NV. Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond). 2008;22(6):855\u20139.","journal-title":"Eye (Lond)"},{"key":"389_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ebiom.2018.11.029","volume":"38","author":"K Little","year":"2018","unstructured":"Little K, Ma JH, Yang N, Chen M, Xu H. Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration - the potential sources and molecular cues for their recruitment and activation. EBioMedicine. 2018;38:283\u201391. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.029.","journal-title":"EBioMedicine"},{"issue":"1","key":"389_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12974-022-02546-3","volume":"19","author":"M Llori\u00e1n-Salvador","year":"2022","unstructured":"Llori\u00e1n-Salvador M, Byrne EM, Szczepan M, Little K, Chen M, Xu H. Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells. J Neuroinflammation. 2022;19(1):182. https:\/\/doi.org\/10.1186\/s12974-022-02546-3.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"389_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s12276-022-00778-0","volume":"54","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Zhang Y, Zhang C, Zhang J, Luo X, Qiu Q, Luo D, Zhang J. TGF-\u03b2 promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2\/3 and Akt\/mTOR pathways. Exp Mol Med. 2022;54(5):673\u201384. https:\/\/doi.org\/10.1038\/s12276-022-00778-0.","journal-title":"Exp Mol Med"},{"key":"389_CR45","doi-asserted-by":"publisher","unstructured":"Huang C, Ogawa R. The vascular involvement in soft tissue fibrosis-lessons learned from pathological scarring. Int J Mol Sci. 2020;21(7). https:\/\/doi.org\/10.3390\/ijms21072542","DOI":"10.3390\/ijms21072542"},{"issue":"12","key":"389_CR46","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.cellsig.2015.09.003","volume":"27","author":"M Agassandian","year":"2015","unstructured":"Agassandian M, Tedrow JR, Sembrat J, Kass DJ, Zhang Y, Goncharova EA, Kaminski N, Mallampalli RK, Vuga LJ. VCAM-1 is a TGF-\u03b21 inducible gene upregulated in idiopathic pulmonary fibrosis. Cell Signal. 2015;27(12):2467\u201373. https:\/\/doi.org\/10.1016\/j.cellsig.2015.09.003.","journal-title":"Cell Signal"},{"issue":"2","key":"389_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.atherosclerosis.2007.10.015","volume":"198","author":"EJ Petersen","year":"2008","unstructured":"Petersen EJ, Miyoshi T, Yuan Z, Hirohata S, Li JZ, Shi W, Angle JF. siRNA silencing reveals role of vascular cell adhesion molecule-1 in vascular smooth muscle cell migration. Atherosclerosis. 2008;198(2):301\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.10.015.","journal-title":"Atherosclerosis"},{"issue":"1","key":"389_CR48","doi-asserted-by":"publisher","first-page":"21194","DOI":"10.1038\/s41598-020-78320-3","volume":"10","author":"R Takahashi","year":"2020","unstructured":"Takahashi R, Ijichi H, Sano M, Miyabayashi K, Mohri D, Kim J, Kimura G, Nakatsuka T, Fujiwara H, Yamamoto K, Kudo Y, Tanaka Y, Tateishi K, Nakai Y, Morishita Y, Soma K, Takeda N, Moses HL, Isayama H, Koike K. Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer. Sci Rep. 2020;10(1):21194. https:\/\/doi.org\/10.1038\/s41598-020-78320-3.","journal-title":"Sci Rep"},{"issue":"15","key":"389_CR49","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.3390\/ijms22158334","volume":"22","author":"A Abaurrea","year":"2021","unstructured":"Abaurrea A, Araujo AM, Caffarel MM. The role of the IL-6 cytokine family in epithelial-mesenchymal plasticity in cancer progression. Int J Mol Sci. 2021;22(15):8334. https:\/\/doi.org\/10.3390\/ijms22158334.","journal-title":"Int J Mol Sci."}],"container-title":["Immunity &amp; Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-023-00389-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-023-00389-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-023-00389-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:42:44Z","timestamp":1700462564000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/s12979-023-00389-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1186\/s12979-023-00389-x","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of Aier Eye Hospital Group (Ethical number: AIER2019IRB12) and consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}